tiprankstipranks
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
4512
Wakamoto Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4512 full AI Analyst Report?

Wakamoto Pharmaceutical Co., Ltd. (4512) Ratios

0 Followers

Wakamoto Pharmaceutical Co., Ltd. Ratios

JP:4512's free cash flow for Q3 2023 was ¥0.48. For the 2023 fiscal year, JP:4512's free cash flow was decreased by ¥ and operating cash flow was ¥0.04. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 3.48 3.48 4.38 4.96 4.18
Quick Ratio
 2.07 2.07 2.88 3.85 3.31
Cash Ratio
 0.72 0.72 1.45 2.03 1.73
Solvency Ratio
 0.15 0.15 0.15 0.13 0.13
Operating Cash Flow Ratio
 0.00 -0.18 -0.29 -0.06 0.28
Short-Term Operating Cash Flow Coverage
 0.00 -3.52 -5.92 -0.82 4.64
Net Current Asset Value
¥ 5.18B¥ 5.18B¥ 5.52B¥ 5.57B¥ 5.55B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.03 0.03 <0.01 0.01 0.01
Debt-to-Capital Ratio
 0.03 0.03 <0.01 0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.00 0.00 0.00
Financial Leverage Ratio
 1.37 1.37 1.29 1.28 1.32
Debt Service Coverage Ratio
 5.02 4.77 4.91 3.48 3.67
Interest Coverage Ratio
 134.85 134.85 -519.04 -368.19 244.75
Debt to Market Cap
 0.04 0.03 <0.01 0.02 0.02
Interest Debt Per Share
 11.58 11.58 2.91 3.78 3.99
Net Debt to EBITDA
 -2.19 -2.30 -6.51 -7.00 -6.50
Profitability Margins
Gross Profit Margin
47.75%47.75%46.50%45.76%47.44%
EBIT Margin
2.94%2.58%0.11%2.06%2.45%
EBITDA Margin
7.41%7.05%5.63%6.52%6.65%
Operating Profit Margin
2.58%2.58%-5.88%-2.53%1.63%
Pretax Profit Margin
2.59%2.59%0.10%2.05%2.44%
Net Profit Margin
2.29%2.29%0.83%1.41%1.60%
Continuous Operations Profit Margin
2.29%2.29%0.83%1.41%1.60%
Net Income Per EBT
88.62%88.62%864.27%68.59%65.35%
EBT Per EBIT
100.33%100.33%-1.63%-81.25%149.56%
Return on Assets (ROA)
1.38%1.38%0.43%0.71%0.88%
Return on Equity (ROE)
1.93%1.89%0.56%0.91%1.16%
Return on Capital Employed (ROCE)
1.86%1.86%-3.53%-1.44%1.05%
Return on Invested Capital (ROIC)
1.63%1.63%-3.50%-0.98%0.68%
Return on Tangible Assets
1.40%1.40%0.44%0.72%0.89%
Earnings Yield
2.35%1.87%0.59%1.36%1.61%
Efficiency Ratios
Receivables Turnover
 2.81 2.81 2.97 2.69 2.69
Payables Turnover
 5.15 5.15 4.43 4.75 4.37
Inventory Turnover
 1.32 1.32 1.37 2.09 2.33
Fixed Asset Turnover
 2.71 2.71 2.35 2.56 2.86
Asset Turnover
 0.60 0.60 0.52 0.50 0.55
Working Capital Turnover Ratio
 1.45 1.44 1.11 1.08 1.26
Cash Conversion Cycle
 335.40 335.40 307.77 233.13 208.53
Days of Sales Outstanding
 129.76 129.76 123.08 135.59 135.46
Days of Inventory Outstanding
 276.53 276.53 267.10 174.43 156.58
Days of Payables Outstanding
 70.90 70.90 82.40 76.89 83.51
Operating Cycle
 406.29 406.29 390.17 310.02 292.04
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 -14.03 -17.07 -3.09 18.21
Free Cash Flow Per Share
 0.00 -30.30 -30.04 -19.10 12.12
CapEx Per Share
 0.00 16.27 12.97 16.01 6.08
Free Cash Flow to Operating Cash Flow
 0.00 2.16 1.76 6.18 0.67
Dividend Paid and CapEx Coverage Ratio
 0.00 -0.73 -1.07 -0.16 2.99
Capital Expenditure Coverage Ratio
 0.00 -0.86 -1.32 -0.19 2.99
Operating Cash Flow Coverage Ratio
 0.00 -1.22 -5.92 -0.82 4.59
Operating Cash Flow to Sales Ratio
 0.00 -0.05 -0.08 -0.01 0.07
Free Cash Flow Yield
0.00%-8.63%-9.48%-8.27%4.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.63 53.61 170.73 73.58 62.01
Price-to-Sales (P/S) Ratio
 0.93 1.23 1.41 1.04 0.99
Price-to-Book (P/B) Ratio
 0.77 1.01 0.95 0.67 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 -11.59 -10.55 -12.09 20.37
Price-to-Operating Cash Flow Ratio
 0.00 -25.02 -18.57 -74.69 13.57
Price-to-Earnings Growth (PEG) Ratio
 -0.05 0.21 -4.19 -3.49 -1.47
Price-to-Fair Value
 0.77 1.01 0.95 0.67 0.72
Enterprise Value Multiple
 10.39 15.14 18.57 8.88 8.39
Enterprise Value
 8.08B 10.58B 8.15B 4.48B 4.83B
EV to EBITDA
 11.00 15.14 18.57 8.88 8.39
EV to Sales
 0.82 1.07 1.05 0.58 0.56
EV to Free Cash Flow
 0.00 -10.06 -7.81 -6.76 11.48
EV to Operating Cash Flow
 0.00 -21.72 -13.75 -41.77 7.65
Tangible Book Value Per Share
 345.99 346.01 326.53 336.22 337.24
Shareholders’ Equity Per Share
 345.99 346.01 334.53 346.51 343.06
Tax and Other Ratios
Effective Tax Rate
 0.11 0.11 -7.64 0.31 0.35
Revenue Per Share
 285.43 285.45 224.44 222.97 249.53
Net Income Per Share
 6.55 6.55 1.86 3.14 3.98
Tax Burden
 0.89 0.89 8.64 0.69 0.65
Interest Burden
 0.88 1.00 0.89 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.05 0.07 0.07
SG&A to Revenue
 0.45 0.45 0.52 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 -2.14 -9.19 -0.68 2.99
Currency in JPY